Portfolio (Quarterly)
Guide ↗
Trails Edge Capital Partners, LP
· CIK 0002077247| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 333,312.0 | $30.8M | 7.05% | +301K | +946.1% | $92.38 | +3.4% |
| 2 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 1,047,935.0 | $22.6M | 5.18% | +132K | +14.4% | $21.60 | +8.3% |
| 3 | — | INHIBIKASE THERAPEUTICS INC | — | 8,057,345.0 | $13.5M | 3.10% | +1.9M | +30.4% | $1.68 | — |
| 4 | IMVT | IMMUNOVANT INC | Healthcare | 414,054.0 | $10.3M | 2.36% | +174K | +72.4% | $24.84 | +6.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%